934 related articles for article (PubMed ID: 24007567)
21. Validation of a simple model for predicting liver fibrosis in HIV/hepatitis C virus-coinfected patients.
Al-Mohri H; Cooper C; Murphy T; Klein MB
HIV Med; 2005 Nov; 6(6):375-8. PubMed ID: 16268817
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic accuracy of APRI, FIB-4 and Forns for the detection of liver cirrhosis in HIV/HCV-coinfected patients.
Merli M; Galli L; Castagna A; Salpietro S; Gianotti N; Messina E; Poli A; Morsica G; Bagaglio S; Cernuschi M; Bigoloni A; Uberti-Foppa C; Lazzarin A; Hasson H
New Microbiol; 2016 Apr; 39(2):110-3. PubMed ID: 27196548
[TBL] [Abstract][Full Text] [Related]
23. Acoustic radiation force impulse elastography and serum fibrosis markers in chronic hepatitis C.
Silva Junior RG; Schmillevitch J; Nascimento Mde F; Miranda ML; Brant PE; Schulz PO; Vieira A; Szutan LA
Scand J Gastroenterol; 2014 Aug; 49(8):986-92. PubMed ID: 24742130
[TBL] [Abstract][Full Text] [Related]
24. Modified spleen stiffness measurement by transient elastography is associated with presence of large oesophageal varices in patients with compensated hepatitis C virus cirrhosis.
Calvaruso V; Bronte F; Conte E; Simone F; Craxì A; Di Marco V
J Viral Hepat; 2013 Dec; 20(12):867-74. PubMed ID: 24304456
[TBL] [Abstract][Full Text] [Related]
25. Liver Fibrosis Evaluation Using Real-time Shear Wave Elastography in Hepatitis C-Monoinfected and Human Immunodeficiency Virus/Hepatitis C-Coinfected Patients.
Verlinden W; Bourgeois S; Gigase P; Thienpont C; Vonghia L; Vanwolleghem T; Michielsen P; Francque S
J Ultrasound Med; 2016 Jun; 35(6):1299-308. PubMed ID: 27151906
[TBL] [Abstract][Full Text] [Related]
26. Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis C: new algorithms are more precise and entirely noninvasive.
Boursier J; de Ledinghen V; Zarski JP; Fouchard-Hubert I; Gallois Y; Oberti F; Calès P;
Hepatology; 2012 Jan; 55(1):58-67. PubMed ID: 21898504
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic accuracy of the APRI, FIB-4, and the Forns index for predicting liver fibrosis in HIV/HCV-coinfected patients: a validation study.
Resino S; Asensio C; Bellón JM; Carmona R; Miralles P; López JC; Cosín J; Álvarez E; Berenguer J
J Infect; 2011 Nov; 63(5):402-5. PubMed ID: 21839774
[No Abstract] [Full Text] [Related]
28. Comparison of three algorithms of non-invasive markers of fibrosis in chronic hepatitis C.
Sebastiani G; Halfon P; Castera L; Mangia A; Di Marco V; Pirisi M; Voiculescu M; Bourliere M; Alberti A
Aliment Pharmacol Ther; 2012 Jan; 35(1):92-104. PubMed ID: 22035045
[TBL] [Abstract][Full Text] [Related]
29. Evaluating Diagnostic Accuracy of Noninvasive Tests in Assessment of Significant Liver Fibrosis in Chronic Hepatitis C Egyptian Patients.
Omran D; Zayed RA; Nabeel MM; Mobarak L; Zakaria Z; Farid A; Hassany M; Saif S; Mostafa M; Saad OK; Yosry A
Viral Immunol; 2018 May; 31(4):315-320. PubMed ID: 29630460
[TBL] [Abstract][Full Text] [Related]
30. The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection.
Vergara S; Macías J; Rivero A; Gutiérrez-Valencia A; González-Serrano M; Merino D; Ríos MJ; García-García JA; Camacho A; López-Cortés L; Ruiz J; de la Torre J; Viciana P; Pineda JA;
Clin Infect Dis; 2007 Oct; 45(8):969-74. PubMed ID: 17879910
[TBL] [Abstract][Full Text] [Related]
31. Liver stiffness and fibrosis-4 alone better predict liver events compared with aspartate aminotransferase to platelet ratio index in a cohort of human immunodeficiency virus and hepatitis C virus co-infected patients from ANRS CO13 HEPAVIH cohort.
Chalouni M; Sogni P; Miailhes P; Lacombe K; Poizot-Martin I; Chas J; Vittecoq D; Neau D; Aumaitre H; Alric L; Piroth L; Bouchaud O; Katlama C; Morlat P; Lascoux-Combe C; Gervais A; Naqvi A; Rosenthal E; Garipuy D; Barange K; Esterle L; Salmon D; Wittkop L;
Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1387-1396. PubMed ID: 31033848
[TBL] [Abstract][Full Text] [Related]
32. Optimized stepwise combination algorithms of non-invasive liver fibrosis scores including Hepascore in hepatitis C virus patients.
Bourliere M; Penaranda G; Ouzan D; Renou C; Botta-Fridlund D; Tran A; Rosenthal E; Wartelle-Bladou C; Delasalle P; Oules V; Portal I; Castellani P; Lecomte L; Rosenthal-Allieri MA; Halfon P
Aliment Pharmacol Ther; 2008 Aug; 28(4):458-67. PubMed ID: 18498446
[TBL] [Abstract][Full Text] [Related]
33. Assessment of allograft fibrosis by transient elastography and noninvasive biomarker scoring systems in liver transplant patients.
Beckebaum S; Iacob S; Klein CG; Dechêne A; Varghese J; Baba HA; Sotiropoulos GC; Paul A; Gerken G; Cicinnati VR
Transplantation; 2010 Apr; 89(8):983-93. PubMed ID: 20335832
[TBL] [Abstract][Full Text] [Related]
34. [Retrospective study of FibroScan, APRI, FIB-4 and FORNS indexes compared with liver biopsy in the evaluation of liver fibrosis in patients with chronic hepatitis C monoinfection and HIV coinfection].
González Guilabert MI; Hinojosa Mena-Bernal C; del Pozo González J; del Pozo Pérez MA
Gastroenterol Hepatol; 2010; 33(6):425-32. PubMed ID: 20471720
[TBL] [Abstract][Full Text] [Related]
35. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.
Lackner C; Struber G; Liegl B; Leibl S; Ofner P; Bankuti C; Bauer B; Stauber RE
Hepatology; 2005 Jun; 41(6):1376-82. PubMed ID: 15915455
[TBL] [Abstract][Full Text] [Related]
36. Non-invasive biomarkers of liver fibrosis in haemophilia patients with hepatitis C: can you avoid liver biopsy?
Maor Y; Bashari D; Kenet G; Lubetsky A; Luboshitz J; Schapiro JM; Pénaranda G; Bar-Meir S; Martinowitz U; Halfon P
Haemophilia; 2006 Jul; 12(4):372-9. PubMed ID: 16834736
[TBL] [Abstract][Full Text] [Related]
37. The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases.
Sebastiani G; Castera L; Halfon P; Pol S; Mangia A; Di Marco V; Pirisi M; Voiculescu M; Bourliere M; Alberti A
Aliment Pharmacol Ther; 2011 Nov; 34(10):1202-16. PubMed ID: 21981787
[TBL] [Abstract][Full Text] [Related]
38. Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection.
Calès P; Halfon P; Batisse D; Carrat F; Perré P; Penaranda G; Guyader D; d'Alteroche L; Fouchard-Hubert I; Michelet C; Veillon P; Lambert J; Weiss L; Salmon D; Cacoub P
J Hepatol; 2010 Aug; 53(2):238-44. PubMed ID: 20493576
[TBL] [Abstract][Full Text] [Related]
39. [Grade of consistency existing in the grade of hepatic fibrosis calculated with the APRI and FORNS biochemistry indexes and transient elastography (Fibroscan in patients coinfected with HIV-HCV].
Ibáñez JG; Pérez M; Lamas JL; Ocampo A; Vázquez CM; Ribera A
Rev Clin Esp; 2010; 210(7):317-22. PubMed ID: 20466359
[TBL] [Abstract][Full Text] [Related]
40. Suboptimal performance of APRI and FIB-4 in ruling out significant fibrosis and confirming cirrhosis in HIV/HCV co-infected and HCV mono-infected patients.
Mazzola G; Adamoli L; Calvaruso V; Macaluso FS; Colletti P; Mazzola S; Cervo A; Trizzino M; Di Lorenzo F; Iaria C; Prestileo T; Orlando A; Di Marco V; Cascio A
Infection; 2019 Jun; 47(3):409-415. PubMed ID: 30519966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]